Pharmaceutical Product Development’s $550 Million Recapitalization With Existing Owners and New Investors

Simpson Thacher is representing Hellman & Friedman in connection with its entering into definitive agreements to recapitalize Pharmaceutical Product Development, LLC Under the agreements, Hellman &…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now